Logo image of NAR.CA

NORTH ARROW MINERALS INC (NAR.CA) Stock Fundamental Analysis

TSX-V:NAR - TSX Venture Exchange - CA6572805092 - Common Stock - Currency: CAD

0.23  +0.01 (+2.22%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NAR. NAR was compared to 802 industry peers in the Metals & Mining industry. NAR has a great financial health rating, but its profitability evaluates not so good. NAR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

NAR had positive earnings in the past year.
NAR had a negative operating cash flow in the past year.
In the past 5 years NAR always reported negative net income.
In the past 5 years NAR always reported negative operating cash flow.
NAR.CA Yearly Net Income VS EBIT VS OCF VS FCFNAR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

NAR has a Return On Assets of -0.95%. This is amongst the best in the industry. NAR outperforms 83.54% of its industry peers.
With an excellent Return On Equity value of -0.97%, NAR belongs to the best of the industry, outperforming 84.79% of the companies in the same industry.
Industry RankSector Rank
ROA -0.95%
ROE -0.97%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-9.43%
ROE(3y)-14.3%
ROE(5y)-10.14%
ROIC(3y)N/A
ROIC(5y)N/A
NAR.CA Yearly ROA, ROE, ROICNAR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

NAR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NAR.CA Yearly Profit, Operating, Gross MarginsNAR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

9

2. Health

2.1 Basic Checks

NAR has more shares outstanding than it did 1 year ago.
NAR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for NAR has been reduced compared to a year ago.
NAR.CA Yearly Shares OutstandingNAR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NAR.CA Yearly Total Debt VS Total AssetsNAR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

NAR has an Altman-Z score of 11.09. This indicates that NAR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NAR (11.09) is better than 76.06% of its industry peers.
There is no outstanding debt for NAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.09
ROIC/WACCN/A
WACCN/A
NAR.CA Yearly LT Debt VS Equity VS FCFNAR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 10.07 indicates that NAR has no problem at all paying its short term obligations.
NAR has a better Current ratio (10.07) than 85.79% of its industry peers.
NAR has a Quick Ratio of 10.07. This indicates that NAR is financially healthy and has no problem in meeting its short term obligations.
NAR has a better Quick ratio (10.07) than 85.79% of its industry peers.
Industry RankSector Rank
Current Ratio 10.07
Quick Ratio 10.07
NAR.CA Yearly Current Assets VS Current LiabilitesNAR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 129.02% over the past year.
EPS 1Y (TTM)129.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-141.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAR.CA Yearly EPS VS EstimatesNAR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NAR is valuated rather expensively with a Price/Earnings ratio of 23.00.
NAR's Price/Earnings ratio is rather cheap when compared to the industry. NAR is cheaper than 89.28% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 24.21. NAR is around the same levels.
Industry RankSector Rank
PE 23
Fwd PE N/A
NAR.CA Price Earnings VS Forward Price EarningsNAR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAR.CA Per share dataNAR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NAR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NORTH ARROW MINERALS INC

TSX-V:NAR (5/9/2025, 7:00:00 PM)

0.23

+0.01 (+2.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-25 2024-03-25
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners14.84%
Ins Owner ChangeN/A
Market Cap6.57M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 23
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.35
P/tB 0.35
EV/EBITDA N/A
EPS(TTM)0.01
EY4.35%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.66
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.95%
ROE -0.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-13.24%
ROA(5y)-9.43%
ROE(3y)-14.3%
ROE(5y)-10.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2207.99%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.07
Quick Ratio 10.07
Altman-Z 11.09
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1387.2%
Cap/Depr(5y)1002.54%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)129.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-141.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.58%
OCF growth 3YN/A
OCF growth 5YN/A